Literature DB >> 3773537

Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients.

A Ahmad, S Stefani.   

Abstract

The records of 256 patients with nasopharyngeal carcinoma have been reviewed to determine the incidence and location of distant metastases. Sixty-three patients underwent autopsy. The incidence of distant metastases was 36% overall, and 51% in the autopsy patients. Bones, distant lymphnodes, liver, and lungs were the most common sites of distant metastases. Liver was the most common site in the autopsy patients. Compared to other major histological subtypes, undifferentiated carcinoma had the highest incidence of bone but lowest incidence of lung metastases. There was a strong correlation between advanced locoregional disease and distant metastases. Of those patients who developed distant metastases, 98% were discovered within 3 years or earlier. Thorough evaluation of the above organs/systems is indicated at the time of initial staging work-up and at follow-up, specifically for patients with advanced locoregional disease. A literature review of distant metastases in nasopharyngeal carcinoma is presented.

Entities:  

Mesh:

Year:  1986        PMID: 3773537     DOI: 10.1002/jso.2930330310

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  36 in total

Review 1.  Nasopharyngeal carcinoma.

Authors:  Muhyi Al-Sarraf; Maryada S Reddy
Journal:  Curr Treat Options Oncol       Date:  2002-02

2.  Pathobiology of selected tumors of the base of the skull.

Authors:  L Barnes
Journal:  Skull Base Surg       Date:  1991

3.  Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.

Authors:  Xiang-Min Li; Wei-Guo Huang; Hong Yi; Ai-Lan Cheng; Zhi-Qiang Xiao
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-16       Impact factor: 4.553

4.  Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis.

Authors:  Dirk M Pegtel; Aravind Subramanian; Tzung-Shiahn Sheen; Ching-Hwa Tsai; Todd R Golub; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.

Authors:  Ying-Na Bao; Xue Cao; Dong-Hua Luo; Rui Sun; Li-Xia Peng; Lin Wang; Yong-Pan Yan; Li-Sheng Zheng; Ping Xie; Yun Cao; Ying-Ying Liang; Fang-Jing Zheng; Bi-Jun Huang; Yan-Qun Xiang; Xing Lv; Qiu-Yan Chen; Ming-Yuan Chen; Pei-Yu Huang; Ling Guo; Hai-Qiang Mai; Xiang Guo; Yi-Xin Zeng; Chao-Nan Qian
Journal:  Cell Cycle       Date:  2014-04-24       Impact factor: 4.534

6.  Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma.

Authors:  Wen-Rong Hu; Yi-Fan Lian; Li-Xia Peng; Jin-Ju Lei; Cheng-Cheng Deng; Miao Xu; Qi-Sheng Feng; Li-Zhen Chen; Jin-Xin Bei; Yi-Xin Zeng
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

7.  Physcion, a naturally occurring anthraquinone derivative, induces apoptosis and autophagy in human nasopharyngeal carcinoma.

Authors:  Ming-Jie Pang; Zhun Yang; Xing-Lin Zhang; Zhao-Fang Liu; Jun Fan; Hong-Ying Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-10-03       Impact factor: 6.150

8.  Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome.

Authors:  Ching-Chih Lee; Tze-Ta Huang; Moon-Sing Lee; Shih-Hsuan Hsiao; Hon-Yi Lin; Yu-Chieh Su; Feng-Chun Hsu; Shih-Kai Hung
Journal:  Radiat Oncol       Date:  2010-03-11       Impact factor: 3.481

9.  Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line.

Authors:  Si Ming Xie; Wei Yi Fang; Teng Fei Liu; Kai Tai Yao; Xue Yun Zhong
Journal:  J Oncol       Date:  2010-06-13       Impact factor: 4.375

10.  Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course.

Authors:  Frederick Y Wu; Eddy S Yang; Christopher D Willey; Kim Ely; Gaelyn Garrett; Anthony J Cmelak
Journal:  Head Neck Oncol       Date:  2009-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.